ROR-gamma inverse agonists (Nestle Skin Health)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameROR-gamma inverse agonists (Nestle Skin Health)
Drug Alias NameSulfoximines derivatives (Nestle Skin Health)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma antagonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsAutoimmune DiseasesPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGalderma Sa
China Registration ClassN/A

Develop Information

Active CompaniesGalderma Sa
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A